Rafey Feroze
Cleveland, OHNPI 1154815553
Payments from drug & device makers
What this record shows
This record is dominated by grants: $97,892 of the $108,604 with a category attached, or 90.1%. 29 manufacturers reported payments, led by Boston Scientific at 46.6% of the total. 2025 is the largest year on record at $81,811, more than ten times the $534 reported in 2021.
Across 168 payments — averaging $646.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$51K
- Medtronic$36K
- Abbott$16K
- Abiomed$2K
- E.r. Squibb & Sons, L.L.C.$673
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$331
- plus $2K from 23 others
Across 1 payment — averaging $41.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$42
What the payments were for
- Grants$97,89290%
- Travel & lodging$2,8763%
- Food & beverage$7,3747%
- Education$4610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $50,641 |
| Medtronic | 33 | $35,673 |
| Abbott | 29 | $16,397 |
| Abiomed | 12 | $2,491 |
| E.r. Squibb & Sons, L.L.C. | 13 | $673 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $331 |
| Atricure, Inc. | 17 | $305 |
| Inari Medical, Inc. | 2 | $289 |
| Amgen | 7 | $233 |
| Edwards Lifesciences | 3 | $179 |
| Terumo Medical Corporation | 2 | $146 |
| Pfizer | 10 | $144 |
| Penumbra, Inc. | 1 | $141 |
| Boehringer Ingelheim | 3 | $141 |
| Cardiva Medical, Inc. | 1 | $131 |
| Teleflex LLC | 1 | $119 |
| Astellas Pharma US Inc | 1 | $100 |
| Gilead | 4 | $90 |
| Novartis | 2 | $80 |
| Lantheus Medical Imaging, Inc. | 3 | $72 |
| Chiesi USA, Inc. | 1 | $70 |
| La Jolla Pharmaceutical Company | 1 | $30 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Bayer | 1 | $20 |
| Organogenesis Inc. | 1 | $20 |
| Convatec Inc. | 1 | $19 |
| Merck | 1 | $19 |
| Sanofi | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - STRUCTURAL HEART$50,000
- XIENCE V$13,500
- Impella$2,241
- OPTIS$1,149
- CAMZYOS$312
- FLOWTRIEVER CATHETER, S$289
- CT THROMBECTOMY SYSTEM KIT$289
- SYMPLICITY G3$275
- DRAGONFLY OPSTAR$241
- GENERAL - THERAPIES$215
- EnSite Precision Cardiac Mapping System$209
- COREVALVE EVOLUT R$159
- AVVIGO Guidance System$154
- ENSITE PRECISION$152
- Diamondback Coronary$148
- HawkOne$146
- JETi Peripheral Catheter$142
- Indigo System$141
- SelectSecure$140
- Cardiva VASCADE MVP VVCS 6-12F$131
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.